387 related articles for article (PubMed ID: 33316425)
21. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
[TBL] [Abstract][Full Text] [Related]
22. Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification.
Kim M; Hwang S; Ahn CS; Kim KH; Moon DB; Song GW; Jung DH; Hong SM
Asian J Surg; 2021 Nov; 44(11):1389-1395. PubMed ID: 33766528
[TBL] [Abstract][Full Text] [Related]
23. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
Laohawetwanit T; Lerttanatum N; Wanpiyarat N; Manasilp N; Chaiparnich S
Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma.
Panjala C; Senecal DL; Bridges MD; Kim GP; Nakhleh RE; Nguyen JH; Harnois DM
Am J Transplant; 2010 May; 10(5):1263-7. PubMed ID: 20420633
[TBL] [Abstract][Full Text] [Related]
25. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
[TBL] [Abstract][Full Text] [Related]
26. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
[TBL] [Abstract][Full Text] [Related]
27. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
[TBL] [Abstract][Full Text] [Related]
29. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma.
Granata V; Fusco R; Venanzio Setola S; Sandomenico F; Luisa Barretta M; Belli A; Palaia R; Tatangelo F; Grassi R; Izzo F; Petrillo A
Radiol Oncol; 2020 May; 54(2):149-158. PubMed ID: 32463393
[TBL] [Abstract][Full Text] [Related]
30. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
[TBL] [Abstract][Full Text] [Related]
31. Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
Zhang H; Yu X; Xu J; Li J; Zhou Y
Medicine (Baltimore); 2019 Sep; 98(38):e17102. PubMed ID: 31567946
[TBL] [Abstract][Full Text] [Related]
32. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
33. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis.
De Martin E; Rayar M; Golse N; Dupeux M; Gelli M; Gnemmi V; Allard MA; Cherqui D; Sa Cunha A; Adam R; Coilly A; Antonini TM; Guettier C; Samuel D; Boudjema K; Boleslawski E; Vibert E
Liver Transpl; 2020 Jun; 26(6):785-798. PubMed ID: 32090444
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
[TBL] [Abstract][Full Text] [Related]
35. Liver transplantation for hepatic tumors: a systematic review.
Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?
Irtan S; Barbier L; Francoz C; Dondero F; Durand F; Belghiti J
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):147-51. PubMed ID: 27020630
[TBL] [Abstract][Full Text] [Related]
37. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
Huang X; Li Y; Long L
Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
[TBL] [Abstract][Full Text] [Related]
39. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
Wang C; Chen C; Hu W; Tao L; Chen J
Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
[TBL] [Abstract][Full Text] [Related]
40. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
